Online citations, reference lists, and bibliographies.
← Back to Search

An Insight Into Characterizations And Applications Of Nanoparticulate Targeted Drug Delivery Systems

A. K. Barui, B. Jana, J. Ryu
Published 2019 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Nanoparticle-based targeted drug delivery system (DDS) is one of the major applications of nanotechnology in modern biomedical research. Basically, it comprises of bare or functionalized biocompatible nanoparticles with or without targeting ligands and one or more chemotherapeutic drugs. While the targeting efficacy of DDS without targeting ligands involves passive targeting through enhanced permeability and retention (EPR) effect, DDS containing targeting ligands (e.g., protein, antibodies, peptides, and small molecules) relies on their specificity to cell surface receptors. To achieve combination therapy, two or more chemotherapeutic drugs (exhibiting synergistic effect) are often loaded on nanoparticulate DDS. Besides site-specific delivery, the release of drugs from the DDS and stability of nanomaterials are also important factors to develop an effective nanomedicine that could overcome the disadvantages (e.g., nonspecificity, less bioavailability, and adverse side effect) associated with conventional treatment strategies of different diseases. To comprehend the drug release, stability of nanomaterials as well as ultimate therapeutic applications of DDS, it is highly essential to gradually develop and understand relevant physicochemical and biological characterization techniques. In view of the rapid growth of modern biomedical research involving drug delivery, it might be speculated that many nanomedicines based on DDS would come up in near future for practical therapeutic applications in human.
This paper references
10.1021/acsnano.6b00043
Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
T. Feng (2016)
10.1016/S0168-3659(00)00367-9
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
H. M. Redhead (2001)
10.1021/nn800511k
Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties.
T. Xia (2008)
10.1039/c3cc43487g
A luminescent nanoporous hybrid material based drug delivery system showing excellent theranostics potential for cancer.
A. Modak (2013)
10.1016/j.carbpol.2012.10.022
Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticle for tumor-targeted drug delivery.
Tong Chen (2013)
10.1023/A:1022676709565
Characterization of Crystalline Drug Nanoparticles Using Atomic Force Microscopy and Complementary Techniques
H. Shi (2004)
10.1021/acs.biomac.5b00589
Noncovalent Surface Locking of Mesoporous Silica Nanoparticles for Exceptionally High Hydrophobic Drug Loading and Enhanced Colloidal Stability.
L. Palanikumar (2015)
Carbon nanotechnology : recent developments in chemistry, physics, materials science and device applications
Liming Dai (2006)
10.1016/j.biomaterials.2016.06.007
Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.
J. Park (2016)
10.1021/acsami.5b05335
Colloidal Stability of Silk Fibroin Nanoparticles Coated with Cationic Polymer for Effective Drug Delivery.
Suhang Wang (2015)
10.1038/s41467-018-06979-4
Cloaking nanoparticles with protein corona shield for targeted drug delivery
Jun Yong Oh (2018)
10.1007/978-3-319-41129-3
Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae
Saurabh Bhatia (2016)
10.1021/acsami.6b16669
Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location.
Teng Cui (2017)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
10.1021/acsami.6b04933
pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery.
XiaoLi Cai (2016)
10.1016/j.tibtech.2008.06.009
Bioinspired enzyme encapsulation for biocatalysis.
Lorena Betancor (2008)
10.1021/nl104263j
Oriented catalytic platinum nanoparticles on high surface area strontium titanate nanocuboids.
J. A. Enterkin (2011)
10.1038/nnano.2011.149
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy.
N. Cho (2011)
10.3390/APP7010049
FTIR and Raman Characterization of TiO2 Nanoparticles Coated with Polyethylene Glycol as Carrier for 2-Methoxyestradiol
A. León (2017)
10.1021/ja804947u
Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles.
J. R. Hwu (2009)
10.1016/j.jconrel.2011.06.001
Targeted drug delivery to tumors: myths, reality and possibility.
Y. Bae (2011)
10.1039/C5TB00244C
A green chemistry approach for the synthesis of gold nanoconjugates that induce the inhibition of cancer cell proliferation through induction of oxidative stress and their in vivo toxicity study.
S. Mukherjee (2015)
10.1021/ja803688x
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs.
Zhuang Liu (2008)
10.1021/ja908117a
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
S. D. Brown (2010)
10.1002/ADFM.201402755
Noncovalent Polymer‐Gatekeeper in Mesoporous Silica Nanoparticles as a Targeted Drug Delivery Platform
L. Palanikumar (2015)
10.2147/IJN.S122666
Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis
Y. Li (2016)
10.1039/C5TB00994D
Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells.
F. Benyettou (2015)
10.1016/j.biomaterials.2009.05.015
The incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskers.
Q. Li (2009)
10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
10.1007/978-3-642-00477-3_1
Passive and active drug targeting: drug delivery to tumors as an example.
V. Torchilin (2010)
10.1039/C4RA07424F
meso-Substituted BODIPY fluorescent probes for cellular bio-imaging and anticancer activity
T. Gayathri (2014)
10.1021/acsami.6b07583
Doxorubicin-Incorporated Nanotherapeutic Delivery System Based on Gelatin-Coated Gold Nanoparticles: Formulation, Drug Release, and Multimodal Imaging of Cellular Internalization.
S. Suarasan (2016)
10.1158/1078-0432.CCR-10-0978
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
S. Libutti (2010)
10.1039/C6TB03323G
Investigation of the role of nitric oxide driven angiogenesis by zinc oxide nanoflowers.
A. K. Barui (2017)
10.1016/j.biomaterials.2013.10.057
Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery.
J. Chen (2014)
10.1016/j.biomaterials.2011.11.004
Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors.
L. Meng (2012)
10.1016/j.addr.2011.09.001
Toxicology of nanoparticles.
A. Elsaesser (2012)
10.1016/j.msec.2017.05.065
Functionalization of ZnO nanoparticles by 3-mercaptopropionic acid for aqueous curcumin delivery: Synthesis, characterization, and anticancer assessment.
Seyed-Behnam Ghaffari (2017)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
Nanoparticle arrays on surfaces for electronic, optical, and sensor applications.
A. N. Shipway (2000)
10.1023/A:1016042504830
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
A. Mühlen (2004)
10.1016/S0168-3659(99)00012-7
Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release.
M. Polakovič (1999)
10.1039/c5bm00552c
Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment.
Rajesh Kotcherlakota (2016)
10.1021/JA307589N
Applications of colloidal inorganic nanoparticles: from medicine to energy.
Samuel E. Lohse (2012)
10.1021/NL061412U
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.
N. Nasongkla (2006)
10.1016/0168-3659(91)90140-9
Polymer-coated liposomes; stability and release of ASA from carboxymethyl chitin-coated liposomes
C. Dong (1991)
10.1021/am100840c
Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier.
Pallab Sanpui (2011)
10.1002/9783527610419.NTLS0105
Nanoparticles and Nanowires for Cellular Engineering
J. Winter (2007)
10.1021/JA805570F
Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.
Jingyi Chen (2008)
10.1039/C5RA03083H
Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44+ cancer cells
Jianming Liang (2015)
10.1021/nn302538y
Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection.
M. Lee (2012)
10.1021/ACSBIOMATERIALS.8B00218
Hyaluronic Acid-Modified Polymeric Gatekeepers on Biodegradable Mesoporous Silica Nanoparticles for Targeted Cancer Therapy
L. Palanikumar (2018)
10.1016/j.carbpol.2015.04.010
Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells).
C. Senthil Kumar (2015)
10.1021/nn9011225
P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
Ruibin Li (2010)
10.1016/j.actbio.2014.11.010
Potential application of functional porous TiO2 nanoparticles in light-controlled drug release and targeted drug delivery.
T. Wang (2015)
10.1016/j.biomaterials.2012.01.025
The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Jinfeng Ren (2012)
10.1016/J.CROPRO.2012.01.007
Applications of nanomaterials in agricultural production and crop protection: A review
Lav R. Khot (2012)
10.1016/0378-5173(83)90113-8
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
10.1021/acsami.6b10914
Carbon-Dot-Coated Alginate Beads as a Smart Stimuli-Responsive Drug Delivery System.
S. Majumdar (2016)
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.1016/j.ijbiomac.2016.01.038
pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
H. Chen (2016)
10.1016/j.msec.2017.02.115
Study on montmorillonite/insulin/TiO2 hybrid nanocomposite as a new oral drug-delivery system.
Younes Kamari (2017)
10.1016/S0169-409X(02)00226-0
PEGylated Nanoparticles for Biological and Pharmaceutical Applications
H. Otsuka (2003)
10.1021/ja402903h
Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles.
Xinyu Wang (2013)
10.1039/c5cp02139a
Synergistically enhanced photocatalytic and chemotherapeutic effects of aptamer-functionalized ZnO nanoparticles towards cancer cells.
Zhou Han (2015)
10.1016/j.msec.2016.03.011
Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells.
V. S. Bollu (2016)
10.1021/BK-2013-1124.CH012
Chapter Green Nanotechnology: Development of Nanomaterials for Environmental and Energy Applications
R. Fagan (2013)
10.1021/acs.jmedchem.5b00651
Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.
P. Nagababu (2015)
10.2174/138161210791208992
Nanotechnology and nanomedicine: going small means aiming big.
M. K. Teli (2010)
10.1080/026520400417658
Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
J. Molpeceres (2000)
10.1039/B914071A
Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers
S. Aryal (2009)
Nanoscience: The Science of the Small in Physics, Engineering, Chemistry, Biology and Medicine
H. Schaefer (2010)
10.1021/mp200006f
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.
Qimeng Quan (2011)
10.1166/JBN.2012.1437
Folic acid protected silver nanocarriers for targeted drug delivery.
Y. Wang (2012)
10.1021/acs.langmuir.6b00214
Functionalized Silica Nanoparticles As an Alternative Platform for Targeted Drug-Delivery of Water Insoluble Drugs.
L. F. de Oliveira (2016)
10.1039/c4nr00974f
Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle.
S. Sau (2014)
10.1016/J.JCONREL.2003.11.012
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
K. Jores (2004)
10.1016/j.biomaterials.2009.07.025
Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes.
X. Zhang (2009)
10.1016/j.ijbiomac.2017.08.048
Fabrication of chitosan/poly(lactic acid)/graphene oxide/TiO2 composite nanofibrous scaffolds for sustained delivery of doxorubicin and treatment of lung cancer.
S. Samadi (2018)



Semantic Scholar Logo Some data provided by SemanticScholar